Althea Group Holdings (AGH) has cited recent media coverage of its US cannabis beverage operations, particularly the commencement of production in Florida via subsidiary Peak USA, as a possible reason for increased trading in its shares.
The ASX issued a price query after AGH shares climbed from a low of $0.039c at close of trading on Thursday (October 10) to a high of $0.046c on Friday. Shares are currently trading at $0.045c (Monday, October 14).
As well as positive sentiment around AGH’s potential in the North American beverages sector, the firm noted “the broader performance of cannabis stocks on the ASX” recently, including positive movement for Cann Group and Ecofibre, “which may reflect positive sentiment in the sector”.
It added: “For completeness, AGH is also evaluating a potential sale of one of its non-core business units. However, these discussions are incomplete, with no binding terms agreed, and there is no certainty that a transaction will occur. As such, there is no further meaningful information to disclose at this stage.”
Byron Bay Bio
Byron Bay Bio’s Birchal crowdfunding campaign closed on Friday (October 11) having raised A$400,623 from 197 investors.
Among the technology-cum-product supplier’s goals are an initiative to patent seeds through DNA genome sequencing and the registration of an over-the-counter CBD muscle balm.
